Status:
COMPLETED
Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes
Lead Sponsor:
University of Pisa
Conditions:
Type 2 Diabetes
Metabolic Control
Eligibility:
All Genders
18-85 years
Brief Summary
The strict rules applied in Italy during the recent COVID-19 pandemic, with the prohibition to attend any regular outdoor activity, are likely to influence the degree of metabolic control of patients ...
Detailed Description
All the patients with type 2 diabetes who were previously scheduled for a follow-up visit in our outpatient diabetes clinic during the lockdown for COVID-19 (March 9, 2020-May 04, 2020) were contacted...
Eligibility Criteria
Inclusion
- type 2 diabetes
- at least two previous clinical records in the last two years
Exclusion
- age \>85 years
- first access to the outpatient clinic
- type 1 diabetes
Key Trial Info
Start Date :
March 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04501991
Start Date
March 11 2020
End Date
June 30 2020
Last Update
August 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pisa
Pisa, Italy, 56125